Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP518301.RAKjQJFeLW4ou9aW6O3b46PwGXrWzwUlAfGfYTZfr5RV0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP518301.RAKjQJFeLW4ou9aW6O3b46PwGXrWzwUlAfGfYTZfr5RV0130_assertion type Assertion NP518301.RAKjQJFeLW4ou9aW6O3b46PwGXrWzwUlAfGfYTZfr5RV0130_head.
- NP518301.RAKjQJFeLW4ou9aW6O3b46PwGXrWzwUlAfGfYTZfr5RV0130_assertion description "[The model vaccine consisted of a polyepitope made of three CTL epitopes from lymphocytic choriomeningitis virus (LCMV), the V3 region of human immunodeficiency virus gp120, and chicken ovalbumin, inserted at three different sites of the catalytic domain of genetically detoxified CyaA.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP518301.RAKjQJFeLW4ou9aW6O3b46PwGXrWzwUlAfGfYTZfr5RV0130_provenance.
- NP518301.RAKjQJFeLW4ou9aW6O3b46PwGXrWzwUlAfGfYTZfr5RV0130_assertion evidence source_evidence_literature NP518301.RAKjQJFeLW4ou9aW6O3b46PwGXrWzwUlAfGfYTZfr5RV0130_provenance.
- NP518301.RAKjQJFeLW4ou9aW6O3b46PwGXrWzwUlAfGfYTZfr5RV0130_assertion SIO_000772 11462005 NP518301.RAKjQJFeLW4ou9aW6O3b46PwGXrWzwUlAfGfYTZfr5RV0130_provenance.
- NP518301.RAKjQJFeLW4ou9aW6O3b46PwGXrWzwUlAfGfYTZfr5RV0130_assertion wasDerivedFrom befree-20150227 NP518301.RAKjQJFeLW4ou9aW6O3b46PwGXrWzwUlAfGfYTZfr5RV0130_provenance.
- NP518301.RAKjQJFeLW4ou9aW6O3b46PwGXrWzwUlAfGfYTZfr5RV0130_assertion wasGeneratedBy ECO_0000203 NP518301.RAKjQJFeLW4ou9aW6O3b46PwGXrWzwUlAfGfYTZfr5RV0130_provenance.